Dr Nicola Rosenfelder is a GMC-Registered Consultant Clinical Oncologist from London, UK, specializing in neuro-oncology and the treatment of brain metastases and benign intracranial and skull base tumors using stereotactic radiosurgery and stereotactic fractionated radiotherapy. She obtained her medical degree from The University of London in 2000 and completed her oncology training at The Royal Marsden Hospital and Guy's and St Thomas' Hospitals.

Dr Rosenfelder holds an MSc in Oncology, which focused on improving the accuracy of stereotactic intracranial radiotherapy, and an MD, which involved setting up and running clinical trials on image-guided radiotherapy for the treatment of prostate cancer and benign intracranial tumors. She also conducted lab-based research at The Institute of Cancer Research, where she worked on using oncolytic viruses to augment the treatment of prostate cancer. Prior to returning to The Royal Marsden Hospital in 2018, she served as a Consultant Clinical Oncologist at The Royal Free Hospital.

Dr Rosenfelder is currently the Principal Investigator for the ROAM study at The Royal Marsden Hospital and will be opening the SAFER study investigating outcomes in patients undergoing stereotactic radiosurgery for brain metastases.